About Alexander Aravanis
Alexander Aravanis is an executive officer and director at Moonwalk Biosciences.
Alexander Aravanis first appears on SEC filings in 2024.
Experience
This experience comes from Alexander Aravanis's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alexander Aravanis in the role, so the role may have started earlier or lasted longer.
FL
Foresite Labs Current
Advisor
2024 – Present
Moonwalk Biosciences, Inc. Current
Chief Executive Officer and Co-Founder (2023 – Present)
Director
2023 – Present · South San Francisco, CA
Develops fat-tissue-targeted therapies for people with obesity and cardiometabolic diseases.
ON
ONI Current
Board Member
2023 – Present
IL
Illumina
Chief Technology Officer, SVP, Global Head of Research and Product Development at Illumina
2013 – 2023
MT
Myst Therapeutics
Advisor
2020 – 2022
GR
GRAIL
Co-Founder, CSO, Head of R&D at GRAIL
2016 – 2020
SA
Sapphire
VP of Development, Chief Science Officer
2007 – 2013
PD
Pria Diagnostics
VP of Engineering, Co-Founder
2002 – 2006
SP
Stanford University (Depts. Electrical Engineering, Molecular and Cellular Physiology)
Ph.D. Student (1999 – 2005)
M.S. Student (1997 – 1999)
1997 – 2005
HL
Hewlett Packard Labs
Research Intern
1995 – 1996
Key Colleagues at Startups
The people Alexander Aravanis works with at each company, as listed on that company's latest Form D.
Moonwalk Biosciences, Inc. · Form D, Sep 14, 2026
John Liles
VP Biology & Translational Science
Chris Dimitropoulos
Managing Director, Alpha Wave Global
AJ
Arash Jamshidi
President and director
Justin Valley
Co-Founder, Chief Platform Officer
SD
Stephen Djedjos
Executive officer
PB
Paul Burton
Director
EC
Elaine Cheung
Executive officer